Overview

Arctop is a neuroscience software company that bridges the gap between brain signal recording and real-world application. Founded in 2016 with roots in Israeli neuroscience research, the company develops software platforms that translate EEG and other neural signals into actionable metrics for entertainment, wellness, and enterprise use cases.

Software-First Approach

Unlike most BCI companies that develop hardware, Arctop focuses on the software layer — algorithms and platforms that interpret brain signals regardless of the recording device. This hardware-agnostic strategy positions the company to benefit from advances in EEG headsets and wearables from other manufacturers.

Consumer Applications

Arctop targets consumer-facing verticals including entertainment personalization (adapting content to neural engagement metrics), cognitive wellness (monitoring attention and focus), and enterprise productivity (workplace cognitive load assessment). These applications represent the non-medical side of the BCI market.

IP Strategy

The company maintains patent filings across the US, European Patent Office, Israel, Japan, and international bodies, reflecting a global IP strategy that covers both the technical methodology and commercial applications of neural signal processing.